• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠对人尿钠排泄激素的利钠及平滑肌反应:与患者血压和激肽释放酶排泄的关系。

Natriuretic and smooth muscle responses to human urinary natriuretic hormone in rats: relation to blood pressure and kallikrein excretion in patients.

作者信息

Mills I H, Chakravarty B, Brownlee A, Lee G, Mortimer W

出版信息

Clin Exp Hypertens A. 1985;7(5-6):783-92. doi: 10.3109/10641968509077227.

DOI:10.3109/10641968509077227
PMID:2990772
Abstract

Human urine contains a small molecular weight natriuretic substance and similar material isolated from the kidney inhibits Na/K ATPase. Such action on smooth muscle in blood vessels would cause contraction. Human urinary natriuretic material caused contraction of the smooth muscle in the rat anococcygeus muscle and this activity correlated with its natriuretic activity. Known vasoactive substances could not explain the activity of the natriuretic factor when tested on the anococcygeus muscle. The best correlation with blood pressure of the patient was with the log of the ratio of natriuretic activity divided by the kallikrein excretion. A normotensive woman with severe renal failure had very high kallikrein excretion as well as increased natriuretic activity and her data fitted the same correlation as the hypertensives' data.

摘要

人尿中含有一种小分子量的利钠物质,从肾脏分离出的类似物质可抑制钠钾ATP酶。这种对血管平滑肌的作用会导致收缩。人尿利钠物质可引起大鼠肛门尾骨肌平滑肌收缩,且这种活性与其利钠活性相关。在对肛门尾骨肌进行测试时,已知的血管活性物质无法解释利钠因子的活性。与患者血压的最佳相关性是利钠活性除以激肽释放酶排泄量的比值的对数。一名患有严重肾衰竭的血压正常女性激肽释放酶排泄量非常高,利钠活性也增加,她的数据与高血压患者的数据符合相同的相关性。

相似文献

1
Natriuretic and smooth muscle responses to human urinary natriuretic hormone in rats: relation to blood pressure and kallikrein excretion in patients.大鼠对人尿钠排泄激素的利钠及平滑肌反应:与患者血压和激肽释放酶排泄的关系。
Clin Exp Hypertens A. 1985;7(5-6):783-92. doi: 10.3109/10641968509077227.
2
Natriuretic and smooth muscle contracting activities isolated from human urine.
Klin Wochenschr. 1987;65 Suppl 8:60-5.
3
Atrial natriuretic factor and urinary kallikrein in the rat: antagonistic factors?
Can J Physiol Pharmacol. 1984 Jun;62(6):645-9. doi: 10.1139/y84-105.
4
Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.利钠激素——一种钠钾激活的三磷酸腺苷酶的循环抑制剂。其在体液和血压调节中的潜在作用。
Klin Wochenschr. 1981 Nov 16;59(22):1225-30. doi: 10.1007/BF01747753.
5
Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.硝苯地平在原发性高血压中的降压和利钠作用。肾激肽释放酶-激肽-前列腺素系统及肾素-血管紧张素-醛固酮系统的作用
J Clin Hypertens. 1986 Sep;2(3):263-70.
6
Effects of atrial natriuretic peptide on urinary kallikrein excretion and renal function in rats.心房利钠肽对大鼠尿激肽释放酶排泄及肾功能的影响。
Eur J Pharmacol. 1989 Sep 1;168(1):1-6. doi: 10.1016/0014-2999(89)90625-0.
7
Arterial pressure and the natriuretic hormone.
Scott Med J. 1984 Apr;29(2):120-4.
8
[The effect of dopaminergic stimulation and inhibition on the urinary excretion of aldosterone and kallikrein in spontaneously hypertensive rats].[多巴胺能刺激与抑制对自发性高血压大鼠醛固酮和激肽释放酶尿排泄的影响]
Boll Soc Ital Biol Sper. 1983 Oct 30;59(10):1435-41.
9
Sodium transport inhibition, cell calcium, and hypertension. The natriuretic hormone/Na+-Ca2+ exchange/hypertension hypothesis.钠转运抑制、细胞钙与高血压。利钠激素/钠-钙交换/高血压假说。
Am J Med. 1984 Oct 5;77(4A):45-59. doi: 10.1016/s0002-9343(84)80037-6.
10
The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension.循环性钠转运抑制剂(利钠激素?)与高血压的关系。
Medicine (Baltimore). 1983 Sep;62(5):310-26. doi: 10.1097/00005792-198309000-00004.

引用本文的文献

1
Vasoconstrictor effects of endogenous digitalis-like factors extracted from urine of hypertensive patients.
Heart Vessels. 1987;3(3):129-34. doi: 10.1007/BF02058788.